PSA Vice President Professor Mark Naunton MPS[/caption]
A preventable tragedy that changed drug approval forever
Thalidomide’s period of use may have been short but its ramifications have lasted decades, both for people who suffer deformities from its effects and...
Opinion: hospital pharmacists can support improved transitions into aged care
The latest medicine safety report from the Pharmaceutical Society of Australia (PSA), Medicine Safety: Aged Care, shines a light on problems with the safety...
Improving access to HMRs post-cardiac event
Delayed access to Home Medicines Reviews is putting patients hospitalised for cardiac events at risk of another event.
On the right page
For Dr Amy Page FPS, it’s the challenge of building something new that has made her career to date so rewarding.
Verapamil for type 1 diabetes
Recent research has shed light on a potential new avenue to reduce insulin requirements for people with type 1 diabetes.
An estimated 1.2 million Australians...
Bitter pills
With three deaths a day involving opioid use, Thea Cowie explores what role pharmacists can play in reducing the toll and ensuring the safe use of opioids.
